Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency Pharmaceutical Investing
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson Pharmaceutical Investing
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 Pharmaceutical Investing
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology Pharmaceutical Investing
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis Pharmaceutical Investing
Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals Pharmaceutical Investing
